AngioDynamics (ANGO) News Today $9.46 -0.11 (-1.15%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Trexquant Investment LP Reduces Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Trexquant Investment LP lessened its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 70.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 81,771 shares of the medical instruments supplier's stock afterApril 14 at 4:04 AM | marketbeat.comPrudential Financial Inc. Trims Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Prudential Financial Inc. lessened its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 70.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,366 shares of the medicaApril 13 at 4:02 AM | marketbeat.comHC Wainwright Lifts Earnings Estimates for AngioDynamicsAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Analysts at HC Wainwright lifted their FY2025 earnings per share estimates for AngioDynamics in a research note issued on Monday, April 7th. HC Wainwright analyst Y. Chen now expects that the medical instruments supplier will post earnings per shaApril 12, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Raises Stake in AngioDynamics, Inc. (NASDAQ:ANGO)Arrowstreet Capital Limited Partnership increased its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 293.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 352,544 shares of the medical instruApril 11, 2025 | marketbeat.comHC Wainwright Expects Increased Earnings for AngioDynamicsApril 11, 2025 | americanbankingnews.comShareholders in AngioDynamics (NASDAQ:ANGO) are in the red if they invested three years agoApril 8, 2025 | finance.yahoo.comAngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPSAngioDynamics (NASDAQ:ANGO - Get Free Report) issued its quarterly earnings data on Wednesday. The medical instruments supplier reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The business had revenue of $72.00 million during the quarter, compared to analysts' expectations of $70.30 million. The company's revenue for the quarter was down 4.3% compared to the same quarter last year.April 5, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Updates FY25 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY25 earnings guidance. The company provided EPS guidance of ($0.34)-($0.31) for the period, compared to the consensus estimate of ($0.37). The company also issued revenue guidance of $285-288 millionillion, compared to the consensus estimate of $284.89 millionillion.April 4, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Releases FY 2025 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY 2025 earnings guidance. The company provided EPS guidance of -0.340--0.310 for the period, compared to the consensus estimate of -0.370. The company also issued revenue guidance of $285.0 millionillion-$288.0 millionillion, compared to the consensus estimate of $284.9 millionillion.April 4, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Trims Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO)Mitsubishi UFJ Asset Management Co. Ltd. trimmed its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 23.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 141,160 shares of the medical instruments supApril 4, 2025 | marketbeat.comAngioDynamics targets 14%-16% MedTech growth for fiscal 2025 driven by thrombectomy and NanoKnife adoptionApril 3, 2025 | msn.comAngioDynamics, Inc. (NASDAQ:ANGO) Q3 2025 Earnings Call TranscriptApril 3, 2025 | insidermonkey.comStoneX Group Inc. Takes $981,000 Position in AngioDynamics, Inc. (NASDAQ:ANGO)StoneX Group Inc. bought a new position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 107,083 shares of the medical instruments supplier's stock, valued at approximately $981,000. StoneX Group Inc. owned aApril 3, 2025 | marketbeat.comAngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...April 3, 2025 | gurufocus.comAngioDynamics reports Q3 adjusted EPS (8c), consensus (13c)April 3, 2025 | markets.businessinsider.comAngioDynamics up 13% in pre-market at $10.90 after Q3 results, guidance raiseApril 3, 2025 | markets.businessinsider.comQ3 2025 AngioDynamics Inc Earnings Call TranscriptApril 3, 2025 | gurufocus.comMedical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual GuidanceApril 2, 2025 | benzinga.comAngioDynamics to Host Virtual Cardiovascular Investor EventApril 2, 2025 | tipranks.comAngioDynamics 3Q Loss Narrows as Operating Expenses Slim DownApril 2, 2025 | marketwatch.comAngioDynamics Reports Fiscal Year 2025 Third Quarter Financial ResultsApril 2, 2025 | investing.comAngioDynamics Reports Fiscal Year 2025 Third Quarter Financial ResultsApril 2, 2025 | businesswire.comUncovering Potential: AngioDynamics's Earnings PreviewApril 1, 2025 | benzinga.comAngioDynamics to Host Virtual Cardiovascular Investor EventMarch 31, 2025 | finance.yahoo.comAngioDynamics Q3 EPS Forecast Decreased by Zacks ResearchAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Research analysts at Zacks Research cut their Q3 2026 EPS estimates for shares of AngioDynamics in a research report issued to clients and investors on Tuesday, March 25th. Zacks Research analyst D. Dey now forecasts that the medical instruments sMarch 29, 2025 | marketbeat.comSegall Bryant & Hamill LLC Has $12.96 Million Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Segall Bryant & Hamill LLC boosted its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 55.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,415,156 shares of the medical instruments supplier's stock afteMarch 27, 2025 | marketbeat.comAngioDynamics (ANGO) Expected to Announce Earnings on WednesdayAngioDynamics (NASDAQ:ANGO) will be releasing earnings before the market opens on Wednesday, April 2, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=676576)March 26, 2025 | marketbeat.comAngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host ...March 19, 2025 | gurufocus.comAngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor EventMarch 19, 2025 | businesswire.comAngioDynamics, Inc. (NASDAQ:ANGO) Shares Acquired by Royce & Associates LPRoyce & Associates LP increased its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 13.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,119,385 shares of the medical instruments supplier'March 18, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $3.56 Million Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Connor Clark & Lunn Investment Management Ltd. lifted its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 69.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 389,053 shares of the medMarch 18, 2025 | marketbeat.comAngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual ConferenceMarch 10, 2025 | finance.yahoo.comQ2 EPS Estimates for AngioDynamics Lifted by Zacks ResearchAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Equities research analysts at Zacks Research lifted their Q2 2026 EPS estimates for shares of AngioDynamics in a report issued on Thursday, March 6th. Zacks Research analyst D. Dey now forecasts that the medical instruments supplier will post earnMarch 10, 2025 | marketbeat.comPrincipal Financial Group Inc. Makes New Investment in AngioDynamics, Inc. (NASDAQ:ANGO)Principal Financial Group Inc. purchased a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 95,961 shares of the medical instrMarch 7, 2025 | marketbeat.comSeveral Insiders Invested In AngioDynamics Flagging Positive NewsFebruary 24, 2025 | finance.yahoo.comAngioDynamics (NASDAQ:ANGO) Stock Price Crosses Above 200 Day Moving Average - What's Next?AngioDynamics (NASDAQ:ANGO) Stock Price Passes Above 200-Day Moving Average - Here's What HappenedFebruary 22, 2025 | marketbeat.comWhite Pine Capital LLC Has $587,000 Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)White Pine Capital LLC raised its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 189.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,033 shares of the medical instruments supplier's stock aFebruary 15, 2025 | marketbeat.comSystematic Financial Management LP's Strategic Acquisition in AngioDynamics IncFebruary 13, 2025 | gurufocus.comShort Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Grows By 78.6%AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 31st, there was short interest totalling 1,470,000 shares, an increase of 78.6% from the January 15th total of 822,900 shares. Based on an average daily trading volume, of 677,900 shares, the short-interest ratio is currently 2.2 days.February 13, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Stock Passes Above 200-Day Moving Average - Should You Sell?AngioDynamics (NASDAQ:ANGO) Shares Pass Above 200 Day Moving Average - Here's What HappenedFebruary 11, 2025 | marketbeat.comAngioDynamics (ANGO) Down 14.2% Since Last Earnings Report: Can It Rebound?February 8, 2025 | msn.comAngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Down 11.8% in JanuaryAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 882,000 shares, a decrease of 11.8% from the December 31st total of 1,000,000 shares. Based on an average trading volume of 625,200 shares, the days-to-cover ratio is presently 1.4 days.January 31, 2025 | marketbeat.comAngioDynamics initiates Auryon Atherectomy System combination studyJanuary 30, 2025 | markets.businessinsider.comAngioDynamics (NASDAQ:ANGO) Hits New 12-Month High - Here's WhyAngioDynamics (NASDAQ:ANGO) Sets New 52-Week High - Should You Buy?January 30, 2025 | marketbeat.comAngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb IschemiaJanuary 30, 2025 | businesswire.comWith 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big gunsJanuary 25, 2025 | finance.yahoo.comAssenagon Asset Management S.A. Reduces Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Assenagon Asset Management S.A. reduced its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 35.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 272,307 shares of the medical instJanuary 23, 2025 | marketbeat.comInsider Selling: AngioDynamics, Inc. (NASDAQ:ANGO) SVP Sells 4,060 Shares of StockJanuary 18, 2025 | insidertrades.comAngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Raised by JPMorgan Chase & Co.JPMorgan Chase & Co. boosted its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 28.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 553,161 shares of the medical instruments supplier's stock afterJanuary 18, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) SVP Warren Nighan, Jr. Sells 4,060 SharesAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) SVP Warren Nighan, Jr. sold 4,060 shares of AngioDynamics stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $12.31, for a total value of $49,978.60. Following the transaction, the senior vice president now owns 41,817 shares of the company's stock, valued at $514,767.27. The trade was a 8.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.January 17, 2025 | marketbeat.com Remove Ads Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address ANGO Media Mentions By Week ANGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGO News Sentiment▼1.140.79▲Average Medical News Sentiment ANGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGO Articles This Week▼83▲ANGO Articles Average Week Remove Ads Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alphatec News Today Integra LifeSciences News Today Orthofix Medical News Today Surmodics News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Abbott Laboratories News Today Intuitive Surgical News Today Boston Scientific News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGO) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANGO Stock Free ANGO Stock Alerts